MyMitochondria — teal mitochondrion icon and my Mitochondria wordmarkScience & Health Powering Your CellsFind a Clinic
Latest edition · Mitochondrial medicine, translated without the hype
Research snapshot · Nov 11, 2026
Follow us on Google
NRG5051 doses first volunteers — mitochondrial drug trial with glowing
Custom illustration for the Research desk.
ALS / Parkinson’s Phase 1

NRG5051 doses first volunteers

Edited by Samael A. Tejada, Founder & Editor-in-Chief

·

The study is testing safety and tolerability in healthy adults. Patient benefit has not yet been established.

Trial report ↗

Join the discussion

To get the conversation started: What questions does this story raise for you? Share them below — every comment is reviewed by our moderators before it appears.

Community discussion only — not medical advice. Every comment is reviewed by our moderators before it appears. Sign in with Google or a free Hyvor account to join in.

Follow MyMitochondria on Google

Site imagery: custom illustrations by MyMitochondria; stock photography via Pexels, Splitshire, StockCake and Vecteezy — illustrative only. Models pictured are not patients, clinicians, endorsers, or cases described in our articles.